APA (7th ed.) Citation

C, G., F, W., M, D., MX, L., AC, C., J, D., . . . G, L. (2021). Preclinical small molecule WEHI-7326 overcomes drug resistance and elicits response in patient-derived xenograft models of human treatment-refractory tumors. Cell death & disease, 12(3), 268. https://doi.org/10.1038/s41419-020-03269-0

Chicago Style (17th ed.) Citation

C, Grohmann, et al. "Preclinical Small Molecule WEHI-7326 Overcomes Drug Resistance and Elicits Response in Patient-derived Xenograft Models of Human Treatment-refractory Tumors." Cell Death & Disease 12, no. 3 (2021): 268. https://doi.org/10.1038/s41419-020-03269-0.

MLA (9th ed.) Citation

C, Grohmann, et al. "Preclinical Small Molecule WEHI-7326 Overcomes Drug Resistance and Elicits Response in Patient-derived Xenograft Models of Human Treatment-refractory Tumors." Cell Death & Disease, vol. 12, no. 3, 2021, p. 268, https://doi.org/10.1038/s41419-020-03269-0.